Sale!

Cardiovascular Biomarkers Pathophysiology and Disease Management Contemporary Cardiology 1st Edition by David Morrow ISBN 978-1617376207 1617376205

Original price was: $50.00.Current price is: $35.00.

Cardiovascular Biomarkers Pathophysiology and Disease Management Contemporary Cardiology 1st Edition David A. Morrow Digital Instant Download

Author(s): David A. Morrow
ISBN(s): 9781597450515, 1597450510
Edition: 1
File Details: PDF, 6.25 MB
Year: 2006
Language: english
SKU: EB-1760394 Category: Tag:

Cardiovascular Biomarkers Pathophysiology and Disease Management Contemporary Cardiology 1st Edition by David A. Morrow- Ebook PDF Instant Download/Delivery:  978-1617376207, 1617376205
Full download Cardiovascular Biomarkers Pathophysiology and Disease Management Contemporary Cardiology 1st Edition after payment

Product details: 

ISBN 10:   1617376205

ISBN 13: 978-1617376207

Author:  David A. Morrow

In the four pages committed to a discussion of myocardial infarction in the first edition of Harrison’s Principles of Internal Medicine, published in 1950, there was no mention of use of the laboratory for management of patients. Thirty years later, when the first edition of Braunwald’s Heart Disease, A Textbook of Cardiovascular Medicine was published, 2 out of the 1943 pages in the text contained a discussion of the laboratory examinations in acute myocardial infarction. Our knowledge base of the multitude of ways that physicians can and should use the clinical chemistry laboratory has expanded dramatically since these classic texts were published. The nomenclature has changed: terms such as “cardiac enzymes” have given way to “cardiac biomarkers. ” The number of assays has multiplied, and the operating characteristics of available assays are impr- ing at a gratifying but dizzying rate. We now use biomarkers to diagnose cardiovascular diseases and also to frame our treatment strategies. Thus, there is a clear need for a scholarly compilation of the state of the art of cardiac biomarkers. Dr. David Morrow has expertly edited an authoritative book that answers this need. The 34 chapters in Cardiovascular Biomarkers: Pathophysiology and Disease Mana- ment were written by a group of individuals who are internationally recognized thought leaders and experts in clinical and laboratory medicine.
 

Table of contents: 

  1. Biomarkers of Necrosis

  2. Biomarkers of Myocardial Necrosis

  3. Analytical Issues for Clinical Use of Cardiac Troponin

  4. Defining Myocardial Infarction

  5. Biomarkers in the Emergency Department

  6. Cardiac Troponin for Risk Assessment and Management of Non-ST-Elevation Acute Coronary Syndrome

  7. Biomarkers of Necrosis for Risk Assessment and Management of ST-Elevation Myocardial Infarction

  8. Cardiac Troponin After Revascularization Procedures

  9. Biomarkers of Necrosis in Heart Failure

  10. Is There a Role for Cardiac Troponin and Other Biomarkers in Patients With Pulmonary Embolism?

  11. Cardiac Troponin in Conditions Other Than Acute Coronary Syndromes

  12. Degradation of Cardiac Troponins

  13. Biomarkers of Ischemia

  14. Developing a Marker of Ischemia

  15. Emerging Biomarkers of Myocardial Ischemia

  16. Biomarkers of Inflammation

  17. Inflammation in Cardiovascular Disease

  18. Analytic Issues for Clinical Use of C-Reactive Protein

  19. C-Reactive Protein as a Tool for Risk Assessment in Primary Prevention

  20. High-Sensitivity C-Reactive Protein for Risk Assessment in Acute Coronary Syndromes

  21. Beyond C-Reactive Protein

  22. Biomarkers of Infection and Risk of Coronary Heart Disease

  23. Biomarkers of Hemodynamic Stress

  24. Biology of Natriuretic Peptides

  25. Analytic Issues for Clinical Use of B-Type Natriuretic Peptide and N-Terminal Pro B-Type Natriuretic Peptide

  26. Clinical Use of Natriuretic Peptides for the Diagnosis and Management of Heart Failure

  27. Natriuretic Peptides in Acute and Chronic Coronary Artery Disease

  28. Novel Markers of Hemodynamic Stress

  29. Biomarkers of Platelet Function and Hemostasis

  30. Clinical and Research Applications of Markers of Thrombosis

  31. Measures of Platelet Activation and Aggregation

  32. Monocyte-Platelet Aggregates in Patients With Ischemic Heart Disease

  33. Biomarkers of Dyslipidemia and Lipid Modification

  34. Measurement of Atherogenic Lipoproteins in Cardiovascular Risk Assessment

  35. Lipoprotein-Associated Phospholipase A2 and Other Lipid-Related Biomarkers in Cardiovascular Disease

  36. Contemporary and Future Applications of Biomarkers in Clinical Care

  37. A Multimarker Approach to Evaluation of Patients With Acute Coronary Syndrome

  38. Cardiac Biomarkers by Point-of-Care Testing

  39. Proteomics and Discovery of Cardiovascular Biomarkers

  40. Genetic Markers in Cardiovascular Disease

People also search for:

    
cardiovascular biomarkers pathophysiology
    
cardiovascular biomarkers
    
cardiovascular disease biomarkers
    
cardiac biomarkers definition
    
cardiac biomarkers heart failure

Tags: David Morrow, Cardiovascular Biomarkers, Pathophysiology and Disease